Genologics Closes Second Round of VC Cash to Help Market Software | GenomeWeb
NEW YORK (GenomeWeb News) — Genologics Life Sciences yesterday said it has closed a second round of private equity financing.
 
Genologics said it plans to use the undisclosed funding primarily to market its bioinformatics software to pharmaceutical labs specializing in proteomics, genomics, and systems biology research.
 
The financing was led by OVP Venture Partners and included investments from Growth Works and Yaletown Venture Partners.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.